Measures microplastics in samples from children with and without bowel disease
Compares microplastics in samples from children with inflammatory bowel disease and without it.
Key facts
- Who runs it
- Medical University of Gdansk
- Where
- Gdansk, PolandSee the site
- Trial code
- Registry title
- Microplastic Analysis in Pediatric Inflammatory Bowel Disease
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 15 Jun 2025
- Planned end
- Jun 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Environmental microplastic exposure
- Record updated
- 30 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children under 18 who are having a clinically needed gut endoscopy. Some have Crohn's disease or ulcerative colitis; others have no IBD.
- Age
- Under 18 years
- Sex
- All sexes
- Disease stage
- One group has confirmed Crohn's disease or ulcerative colitis. The control group has no current or past IBD.
Main reasons for not taking part
- Age 18 years or older
- No informed consent from a legal guardian
- No written assent from the child if aged 13 years or older
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age <18 years
- Undergoing clinically indicated gastrointestinal endoscopy
- For IBD group: confirmed diagnosis of Crohn's disease or ulcerative colitis
- For control group: no current or past diagnosis of IBD
Who cannot take part
- Age 18 years or older
- Lack of written assent from the participant if age ≥13 years
- Lack of informed consent from legal guardian
Where in Poland
- Medical University of Gdańsk, Department of Pediatrics, Gastroenterology, Allergolgy and NutritionGdansk, PolandContact: Dominika Marszk, MDTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main questions it aims to answer are:
Read full original descriptionShow less
Are microplastics detectable in different biological samples from children? Are there differences in microplastic burden between children with and without IBD?
Researchers will collect biological samples including: intestinal tissue (from routine endoscopy), stool, urine, blood.
Raman spectroscopy will be used to detect and characterize microplastics in each sample type. Participants will not receive any medication or intervention as part of this study. All samples will be collected during standard clinical procedures.
The 2 groups in the trial
- Pediatric IBD group
Children diagnosed with inflammatory bowel disease (Crohn's disease or ulcerative colitis) undergoing clinically indicated endoscopy. Biological samples, including intestinal biopsies, stool, urine, and blood, will be collected and analyzed for microplastic content using Raman spectroscopy.
Treatment: Environmental microplastic exposure
- Control group
Children without a diagnosis of IBD undergoing endoscopy for non-inflammatory indications (e.g., polyps, anemia). Biological samples, including intestinal biopsies, stool, urine, and blood, will be collected and analyzed for microplastic content using Raman spectroscopy.
Treatment: Environmental microplastic exposure
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Analysis of Microplastics in Pediatric Inflammatory Bowel Disease Using Raman Spectroscopy: A Multi-Matrix Study
- Plain-language title
- Measures microplastics in samples from children with and without bowel diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 30 September 2025